Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sine oculis-binding protein homolog (SOBP) is a nuclear zinc finger protein encoded by the SOBP gene found on human chromosome 6q21[1][3]. It is implicated in the development of the cochlea (inner ear), as well as broader neural and sensory organ development, particularly based on conservation across species including Drosophila and vertebrates[1][2]. In humans, mutations in SOBP cause an autosomal recessive syndrome (MRAMS), which involves intellectual disability, maxillary protrusion, and strabismus[1][3]. In mice, loss of function leads to hearing loss and abnormal behavior (circling), associated with anatomical defects in the cochlea[1]. SOBP contains conserved motifs found in FCS-type zinc finger domains, suggesting a role in gene regulation, but it is not classified as a classic transcription factor or as a common drug target[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sine oculis-binding protein homolog (SOBP).